Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Linamar Corporation
  6. News
  7. Summary
    LNR   CA53278L1076

LINAMAR CORPORATION

(LNR)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-12-02 pm EST
66.12 CAD   -0.08%
11/30Exro Technologies and Linamar Ready for Operational Tests on an Electronic Axle
MT
11/30Exro Technologies and Linamar Brief: Exro says successfully completed phase one of its integrated e-axle co-development program with strategic partner, and major tier-1 OEM supplier, Linamar Corporation
MT
11/30Exro Technologies and Linamar Brief: Exro Announcing Major Milestone with Linamar e-Axle Phase One Project Completion and Providing Operational Update
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Linamar Corporation MedTech Achieves Certification for Medical Device Manufacturing

08/24/2022 | 05:05pm EST

Linamar Corporation announced its iHub production site has received ISO 13485 certification for medical device production. The achievement is a critical milestone for the company's recently announced MedTech group, clearing the way to Linamar becoming a leading supplier to the global Medical Device markets. ISO 13485:2016 is an internationally recognized standard of quality and safety for the medical device industry.

The management system standard ensures that an organization meets the regulatory requirements specific to the design, manufacture, assembly, and distribution of medical devices. The Linamar iHub, located in Guelph, Ontario, Canada, is the first of Linamar's global facilities to obtain the medical device specific certification from the Internal Standards Organization (ISO). This facility led the initial response to the COVID-19 outbreak, urgently scaling up production efforts to support the manufacture of lifesaving ventilators and critical medical supplies.

The facility is also focused on Innovation for the future, incubating new technologies and ideas around process and product innovation supporting the company's rapid evolution into Advanced Manufacturing.


ę S&P Capital IQ 2022
All news about LINAMAR CORPORATION
11/30Exro Technologies and Linamar Ready for Operational Tests on an Electronic Axle
MT
11/30Exro Technologies and Linamar Brief: Exro says succe..
MT
11/30Exro Technologies and Linamar Brief: Exro Announcing..
MT
11/30Exro Announces Major Milestone with Linamar e-Axle Phase One Project Completion and Pro..
PR
11/30Exro Technologies Inc. Announces Major Milestone with Linamar Corporation E-Axle Phase ..
CI
11/23Linamar Renews Bank Credit Facility for Four Years
MT
11/22Linamar Renews and Extends its Bank Credit Facility
AQ
11/22Linamar Corporation Renews and Extends Its Bank Credit Facility
CI
11/21Linamar Launch In Action : The Thornhill Ventilator Project
AQ
11/21LINAMAR CORPORATION : Ex-dividend day for
FA
More news
Analyst Recommendations on LINAMAR CORPORATION
More recommendations
Financials
Sales 2022 7 886 M 5 855 M 5 855 M
Net income 2022 - - -
Net Debt 2022 27,0 M 20,0 M 20,0 M
P/E ratio 2022 -
Yield 2022 1,26%
Capitalization 4 096 M 3 041 M 3 041 M
EV / Sales 2022 0,52x
EV / Sales 2023 0,47x
Nbr of Employees 27 619
Free-Float 67,1%
Chart LINAMAR CORPORATION
Duration : Period :
Linamar Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LINAMAR CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 66,12 CAD
Average target price 75,25 CAD
Spread / Average Target 13,8%
Managers and Directors
Linda S. Hasenfratz Executive Chairman & Chief Executive Officer
James Daniel Jarrell President, Chief Operating Officer & Director
Dale Schneider Financial Analyst
Mark Stoddart Non-Independent Director
Terry J. Reidel Independent Director
Sector and Competitors